News Chart Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Delayed Deutsche Boerse AG Other stock markets 03:46:25 2024-07-17 EDT			5-day change	1st Jan Change
0.0128 ^EUR	+0.79%		+70.67%	+4.07%

05-30	Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug	MT
05-30	Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease	CI

257c3adc324d2bede825659fb5e686c9.P731LSq9PL7CwXd96stBGhuaSNugjm5XZka7Md8VEN8.ZvevV03yav2r9U8thKUOXVXuGpfq6CQTLTzydpl-fI568I8fE4x7iZX2Jg~f49a22e0f4601481ed063105b242a734